These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32234283)

  • 1. [Pre-exposure antiretroviral prophylaxis for human immunodeficiency virus (HIV) infection].
    Castilla J
    Semergen; 2020 Apr; 46(3):151-152. PubMed ID: 32234283
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
    Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
    J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
    Kalapila AG; Marrazzo J
    Med Clin North Am; 2016 Jul; 100(4):927-50. PubMed ID: 27235622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis in women fails to prevent HIV infection in African study.
    Mayor S
    BMJ; 2015 Feb; 350():h717. PubMed ID: 25663035
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug Resistance During HIV Pre-Exposure Prophylaxis.
    Gibas KM; van den Berg P; Powell VE; Krakower DS
    Drugs; 2019 Apr; 79(6):609-619. PubMed ID: 30963509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexposure prophylaxis for HIV infection.
    Siemieniuk RA; Bogoch II
    N Engl J Med; 2015 Apr; 372(18):1767-8. PubMed ID: 25923561
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    Huang YA; Tao G; Samandari T; Hoover KW
    J Infect Dis; 2018 Jan; 217(4):617-621. PubMed ID: 29145597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis.
    Laeyendecker O; Redd AD; Nason M; Longosz AF; Karim QA; Naranbhai V; Garrett N; Eshleman SH; Abdool Karim SS; Quinn TC
    J Infect Dis; 2015 Sep; 212(5):754-9. PubMed ID: 25712973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV pre-exposure prophylaxis (PrEP).
    Tumarkin E; Siedner MJ; Bogoch II
    BMJ; 2019 Jan; 364():k4681. PubMed ID: 30655299
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance.
    Afassinou K; Chirove F; Govinder KS
    Math Biosci; 2017 Mar; 285():92-101. PubMed ID: 28095307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Özdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing HIV infection: pre-exposure and postexposure prophylaxis.
    Doblecki-Lewis S; Kolber MA
    IUBMB Life; 2014 Jul; 66(7):453-61. PubMed ID: 24975125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy.
    Youle M; Wainberg MA
    J Int Assoc Physicians AIDS Care (Chic); 2003; 2(3):102-5. PubMed ID: 14556428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can HIV Infection Be Prevented With Medication?
    Jin J
    JAMA; 2019 Jun; 321(22):2252. PubMed ID: 31184742
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-Exposure Prophylaxis as a Method for Prevention of Human Immunodeficiency Virus Infection.
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Asher I; Sthoeger Z
    Isr Med Assoc J; 2016 May; 18(5):294-8. PubMed ID: 27430088
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-Exposure Prophylaxis Counseling in a Community Sexual Health Clinic for Men Who Have Sex with Men in Lisbon, Portugal.
    Ribeiro S; Rocha M
    Acta Med Port; 2019 Jun; 32(6):441-447. PubMed ID: 31292025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.